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Abstract
Background: Biliary leaks have been treated with endoscopic management using different techniques with
conflicting results. Furthermore the appropriate rescue therapy for refractory leaks has not been established.
We evaluated the clinical effectiveness of initial endotherapy for postcholecystectomy biliary leaks using an
homogenous approach (sphincterotomy + placement of a 10-French plastic stent) in a large series of patients
as well as the optimal and efficacy of rescue endotherapy for refractory biliary leaks.
Methods: This was a multicenter, retrospective study of 178 patients who underwent endoscopic management of
postcholecystectomy biliary leaks with a combination of biliary sphincterotomy and the placement of a large-bore
(10-French) plastic stent. Data were collected to analyze the clinical outcomes and technical success, efficacy of the
rescue endotherapy and the need for surgery, adverse events and prognostic factors for clinical success of
endotherapy.
Results: Following endotherapy, closure of the leak was accomplished in 162/178 patients (91.0 %). The multivariate
logistic model showed that the type of leak, namely a high-grade biliary leak, was the only independent prognostic
factor associated with treatment failure (OR = 26.78; 95 % CI = 6.59–108.83; P < 0.01). The remaining 16 patients were
treated with multiple plastic stents (MPSs) with a success rate of 62.5 % (10 patients). The use of fewer than 3 plastic
stents (P = 0.023) and a high-grade biliary leak (P = 0.034) were shown to be significant predictors of treatment failure
with MPSs in refractory bile leaks. The 6 patients in whom the placement of MPSs failed were retreated with a fully
cover self-expandable metallic stent (FCSEMS), resulting in closure of the leak in all cases.
Conclusions: Endotherapy of biliary leaks with a combination of biliary sphincterotomy and the placement of a
large-bore plastic stent is associated with a high rate of success (90 %). However in our series there were several
failures using MPSs as a strategy for rescue endotherapy suggesting that refractory biliary leaks should be treated
with FCSEMS especially in patients with high-grade leaks.
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Background
Iatrogenic injury to the biliary tree, namely biliary leaks,
can occur after laparoscopic cholecystectomy in up to 1 %
of cases [1, 2]. In the early years of treatment and in
several published case series, surgery was the primary
treatment for such cases [2–4]. However, the treatment of
bile leaks has evolved into a minimally invasive procedural
technique (i.e., endoscopic retrograde cholangiopancreato-
graphy [ERCP]) in which decreasing or eliminating the
pressure gradient between the bile duct and the duode-
num permits preferential transpapillary bile flow instead
of extravasation through the leak [1–3, 5–12]. Although
the widespread use of ERCP has been shown to be safe
and efficacious, leak closure can be accomplished by dif-
ferent endoscopic interventions, and the optimal endo-
scopic intervention has not established [5, 8]. Biliary
stenting or nasobiliary drainage, with or without sphinc-
terotomy, or biliary sphincterotomy alone can be used to
treat post-operative bile leaks, with similar results [1–3,
5–11]. One group proposed classifying the severity and
treatment of leaks into low grade and high grade, suggest-
ing that complex leaks and high-grade leaks are better
treated with a combination of biliary sphincterotomy and
transpapillary biliary stent placement [3]. However, there
have been reports of leaks being managed with several
endoscopic procedures or even endoscopic treatment fail-
ures, in which operative therapy is required [1, 3, 6, 11].
Clear strategies for treating these refractory biliary leaks
have not emerged, and treatment is provided on an indi-
vidual basis [13–16]. Currently, two types of endoscopic
treatments have been used as an effective rescue therapy
for refractory biliary leaks: 1) the temporary placement of
a fully covered self-expandable metal stent (FCSEMS)
[13–21], and 2) treatment with more than one plastic
stent, which can theoretically manage the refractory bile
leak at a lower cost [13–16]. Despite a large body of data
supporting the use of ERCP in this setting, there has been
no study of a large series of patients treated using standard
and homogeneous approaches to maximize the benefits of
the first endoscopic treatment, a combination of biliary
sphincterotomy and the placement of a large-bore (10-
French) plastic stent. Furthermore, it is unclear which type
of rescue endotherapy should be used after failure of the
initial treatment. It is also unclear which prognostic fac-
tors are associated with the failure of the initial treatment
and the available rescue endotherapy. Therefore, we
conducted a retrospective study of a large series of pa-
tients, with the aim of evaluating the clinical effectiveness
of initial endotherapy for postcholecystectomy biliary
leaks, as well as the optimal and efficacy of rescue
endotherapy for refractory biliary leaks. Additionally, we
evaluated the prognostic factors associated with clinical
success of the initial treatment and different types of res-
cue endotherapy.
Methods
Patients and settings
In this multicentre, single-arm, retrospective clinical
study, interventional endoscopy database records from 4
institutions were retrospectively reviewed to identify all
consecutive patients underwent endoscopic management
for postcholecystectomy biliary leaks between March
2009 and July 2014. The following criteria were used for
inclusion in this study: 1) initial treatment of the biliary
leak with a combination of biliary sphincterotomy and
the placement of a 10-French transpapillary biliary stent;
2) after failure of the initial treatment, the patients were
subjected to a new endotherapy with multiple plastic
stents (MPS); and 3) after pacing the MPS, patients with
a persistent biliary leak were submitted to the temporary
placement of an FCSEMS, and the patients for whom
the placement of an FCSEMS did not close the leak were
considered for surgery. Patients with refractory bile leaks
with aetiology other than postcholecystectomy were
excluded from the study.
Data were collected from various sources, including
patients’ charts (manual and electronic), endoscopic and
radiology reports, clinical notes, our prospective data-
base, follow-up clinic visits and structured telephone
interviews with the treating physicians, patients or fam-
ily during follow-up or at the time of manuscript prepar-
ation. The collected data included patient demographics,
anatomical location and type of biliary leak, technical
success, treatment outcomes, type of stents used, need
for reintervention and adverse events. This study was
conducted at 4 institutions (2 tertiary referral academic
centres and 2 general district hospitals). All patients pro-
vided written informed consent prior to undergoing any
procedures. Each of the institutional review boards
involved in this study approved this research (Ethics
committee of Amadora-Sintra Hospital, ethics commit-
tee of Pulido Valente Hospital-Centro Hospitalar Lisboa
Norte, ethics committee of Capuchos Hospital-Centro
Hospitalar Lisboa Central and ethics committee of Beja
Hospital-Unidade Local de Saúde do Baixo Alentejo).
Endpoints and definitions
The primary endpoint was the clinical success of the
endoscopic management of the biliary leaks, for the initial
and subsequent rescue types of endotherapy, which was
defined as closure of the leak. The secondary endpoints
included technical success, potential risk factors associ-
ated with the leak closure, treatment duration, adverse
events and the need for surgery. After failure of the initial
endotherapy, the bile leaks were considered to be refrac-
tory biliary leaks, which were defined as leaks that failed
to close after endoscopic intervention with a combination
of biliary sphincterotomy and the placement of a 10-
French transpapillary biliary stent, regardless of the biliary
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leak location (e.g., cystic stump, common bile duct/com-
mon hepatic duct, Luschka’s joints) [14]. High-grade bil-
iary leaks were defined as leaks that were observed
fluoroscopically prior to intrahepatic opacification [3]. In
cases in which the bile leak was associated with bile duct
injury, the Amsterdam Classification was used [22]. Leak
closure was considered after the cessation of bile output,
which was defined as biliary drainage of less than 5 ml/
day in the percutaneous drains and was confirmed at the
follow-up ERCP [14]. Endotherapy failure was defined as
persistent biliary drainage through the percutaneous drain
or as a persistent bile leak at follow-up ERCP. Reinterven-
tion was defined as the need for further intervention to
control the leak after the initial endotherapy for the refrac-
tory leak, including repeat ERCP for additional stenting or
surgery. Adverse events were defined as any adverse event
related to the ERCP or stent placement, and adverse
events were carefully monitored using previously deter-
mined definitions [23].
Technique, stents and follow-up
All ERCP procedures were performed with patients placed
in the prone position under sedation with propofol admin-
istered by the anaesthesia staff. All procedures were per-
formed or supervised by 3 experienced pancreatobiliary
endoscopists (the three first authors). During the first
ERCP procedure, a cholangiography was obtained to
document evidence of biliary leakage, as well as the site
and grade of the bile leak and to determine whether there
was an associated major injury of the bile duct, namely a
bile duct stricture resulting from direct surgical trauma.
After documenting the leak, the endoscopist used a stand-
ard protocol that has been used for the last 8 years at the
institutions where the study was conducted, specifically a
combination of biliary sphincterotomy and the placement
of a 10-French transpapillary biliary stent. All plastic
stents used were at least 7 cm long, although the plastic
stent was not routinely inserted above the leak site. For
this treatment, polyethylene stents were used in all cases
(Advanix Biliary Stent, Boston Scientific, Natick, MA,
USA; Cotton-Huibregtse biliary stent, Cook Medical,
Winston-Salem, NC, USA). All patients included in the
study were routinely treated with a percutaneous drain
and monitored, and the drainage output was used to
evaluate the success of endotherapy in closing the biliary
leak. After clinical evidence of complete resolution of the
bile leak, when appropriate, the patients were scheduled
for a second ERCP to remove the plastic stent, and a new
cholangiogram was obtained to document the leak clos-
ure. However, the patients with similar or increased levels
of percutaneous drainage and maintenance or worsening
bilious fluid collection on an abdominal ultrasonography
or a CT scan after first ERCP were considered to have a
refractory bile leak and underwent second ERCP. After
confirming a persistent bile leak, the patients underwent
more than one plastic stent placement. For this treatment,
the endoscopist determined the number and diameter of
the plastic stents to be inserted based on the diameter of
the bile duct itself. After the MPS treatment, the patients
with persistent percutaneous drainage were again consid-
ered to be treatment failures and were submitted to a
third ERCP in which the plastic stents were removed and
a new cholangiogram was performed. Patients with per-
sistent biliary leakage were considered for the placement
of a FCSEMS. For this type of endotherapy, an FCSEMS
with a 10 mm luminal diameter and a length that varied
from 40 to 80 mm was used to allow the stent to be placed
above the leak site in all cases. For endotherapy with a
FCSEMS, two types of stents were used: the WallFlex
(Boston Scientific, Natick, Massachusetts, USA) and the
Niti-S (TaeWoong Medical, Seoul, South Korea). Patients
for whom the temporary placement of a FCSEMS failed to
close the leak were evaluated for surgery.
The follow-up began at the end of the treatment and
leak closure and lasted for three months. Three months
after hospital discharge, the patients were evaluated by
physical examination, blood samples and upper abdominal
ultrasonography. The follow-up was performed by review-
ing the clinical notes of the treating physician, as well as
by reviewing the patients’ manual and electronic charts.
Statistical analysis
The intention-to-treat method was used for all analyses.
The cumulative leak-free survival (clinical success) was
evaluated using the Kaplan-Meier method, and the 95 %
confidence interval (CI) for long-term leak-free survival
was calculated using the Clopper-Pearson (exact) method.
The potential risk factors associated with closing the leak
were assessed using univariate analysis, followed by mul-
tiple logistic regression analysis, as appropriated. The
univariate analysis was conducted using the χ2 test, with
the Monte Carlo simulation (as needed) for categorical
variables and the Mann-Whitney U test and Student’s t
test for continuous variables. All reported P values were
for a two-tailed test, and P < 0.05 was considered to be
statistically significant. All statistical analyses were per-
formed using the SPSS software package, version 22 (Stat-
istical Package for the Social Sciences, IBM Corporation,
Armonk, NY, USA).
Results
Patients
In total, 178 patients (85 males and 93 females) with a me-
dian age of 67 years (range, 23-92 years) were enrolled in
the study. Fourteen patients (7.9 %) required conversion
of laparoscopic cholecystectomy to an open procedure.
Patients were referred to ERCP after a median of 7 days
(range, 1-28 days) if they had a clinical suspicion of a
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postcholecystectomy biliary complication based on symp-
toms (e.g., abdominal pain), abnormal liver-associated en-
zymes or jaundice, imaging studies (e.g., CT scan, upper
abdominal ultrasonography) or biliary leakage from the
drains placed during surgery. The most common bile leak-
age site was the cystic duct stump, which was observed in
109 patients (61.2 %). Twenty-seven patients (15.2 %) had
a biliary leak located at the common bile duct/common
hepatic duct, which was associated with a bile duct injury,
namely a bile duct stricture (Amsterdam type B injury). In
total, high-grade biliary leaks were found in 19 patients
(10.7 %). Of the 178 patients with a post-operative bile
leak, 33 (18.5 %) patients had associated retained common
bile duct stones. Patient baseline data are summarized in
Table 1.
Characteristics of the first endoscopic treatment, leak-free
survival and prognostic factors associated with closure of
the leak
Stent implantation was technically successful in all
patients. The initial endoscopic management of the 178
patients with biliary leaks is shown in Table 2. Regarding
the clinical success of the first endotherapy, a total of 162
of 178 patients (91.0 %) who underwent temporary place-
ment of a 10-French plastic stent and a biliary sphincter-
otomy had their bile leaks closed. In the 162 clinically
successful cases, bile output ceased in the percutaneous
drains after a median time of 6 days (range, 2–9 days), and
the plastic stents were removed after a median period of
67 days (range, 30–67 days). After the initial endoscopic
treatment, the Kaplan-Meier analysis showed that the esti-
mated cumulative mean time of clinical success was
50.7 days (95 % CI: 47.5–53.8 days). By the end of the
initial endotherapy, the leak-free survival rate was 91.0 %
(95 % CI: 86.9–95.1 %) at 30 and 60 days (Fig. 1). The uni-
variate analysis of treatment failure with a combination of
biliary sphincterotomy and the placement of a 10-French
biliary stent is shown in Table 3. Of the 5 evaluated vari-
ables (i.e., sex, age, biliary leak location, type of leak, and
interval between the surgery and the first endoscopic
treatment for bile leak), a biliary leak located at the com-
mon bile duct/common hepatic duct associated with
major injury of the bile duct and a high-grade biliary leak
proved to be statistically significant predictors of treat-
ment failure of a biliary leak with a combination of biliary
sphincterotomy and the placement of a 10-French biliary
stent (P < 0.01). Multivariate logistic analysis (Table 4)
showed that the type of leak, namely a high-grade biliary
leak, was the only independent prognostic factor associ-
ated with treatment failure (OR = 26.78; 95 % CI = 6.59–
108.83; P < 0.01).
Rescue endotherapy for refractory biliary leaks
The remaining 16 patients in whom the initial endoscopic
treatment was unsuccessful were considered to be clinical
failures, and the follow-up ERCP with the removal of the
plastic stent confirmed the persistence of a biliary leak. All
16 patients were retreated with the placement of MPSs.
Table 1 Baseline patient data
Characteristic
Gender
Male, n (%) 85 (47.8)
Female, n (%) 93 (52.2)
Age (years), median (range; mean) 67 (23–92;
63.8)
Indications for cholecystectomy
Acute cholecystitis, n (%) 50 (28.1)
Chronic cholecystitis, n (%) 28 (15.7)
Symptomatic cholelithiasis, n (%) 100 (56.2)
Type of surgery
Laparoscopic cholecystectomy, n (%) 171 (96.1)
Laparoscopic cholecystectomy with conversion, n (%) 7 (3.9)
Site of bile leak, n (%)
Cystic duct stump 109 (61.2)
CBD/CHD 27 (15.2)
Luschka 42 (23.6)
Type of leak, n (%)
High-grade leak 19 (10.7)
Low-grade leak 159 (89.3)
Associated biliary stricture, n (%)
Yes 27 (15.2)
No 151 (84.8)
Time to first ERCP (first biliary stenting) after
cholecystectomy (days), median (range; mean)
7 (1–28; 7.5)
CBD/CHD common bile duct/common hepatic duct
Table 2 Outcomes after endotherapy of postcholecystectomy
biliary leaks in 178 patients with a combination of biliary
sphincterotomy and the placement of 10-French plastic stent,
including adverse events
Outcome
Clinical success of endotherapy, n (%) 162/178 (91.0)
Cessation of bile output in percutaneous drains,
time (days), median (range), mean ± SD
6 (2–9), 5.5 ± 1.4
Duration of stenting, time (days), median
(range), mean ± SD
67 (15–86), 47.1 ± 22.4
Number of patients with high-grade leaks
treated successfully, n (%)
9/19 (47.4)
Number of patients with adverse events, n (%) 9/178 (5.1)
Stent migration 2/178 (1.1)
Bleeding 2/178 (1.1)
Pancreatitis 5/178 (2.8)
SD standard deviation
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At the end of this new endoscopic management, clinical
success was obtained in 10/16 patients (62.5 %). In the
10 patients with clinical success, ceased bile output in
the percutaneous drains was observed after a median
time of 12 days (range, 9–18 days). In this group of 10
successfully treated patients, the median value of the
maximum number of stents simultaneously inserted
was 3 (range, 2–4), and the median maximum stent
diameter was 27 French (range, 20–35.5 French). In the
remaining 6 patients without clinical success, the me-
dian value for the maximum number of stents simul-
taneously inserted was 2 (range, 2–2), and the median
maximum stent diameter was 19.25 French (range,
18.5–20 French). The univariate analysis of treatment
failure with MPSs is shown in Table 5. Of the 6 evalu-
ated variables (sex, age, biliary leak location, type of
leak, maximum stent diameter and maximum number
of stents simultaneously inserted), a high-grade biliary
leak and the use of fewer than 3 plastic stents proved to
be statistically significant predictors of treatment failure
of a refractory biliary leak with MPSs (P < 0.01).
The remaining 6 patients for whom the placement of
MPSs was unsuccessful were retreated with the place-
ment of an FCSEMS. At the end of this new endother-
apy, leak closure was obtained for all patients. In this
group of 6 patients retreated with an FCSEMS, cessa-
tion of bile output in the percutaneous drains was ob-
served after a median time period of 6 days (range, 5–9
days), and the metal stents were removed after a median
period of 26 days (range, 15–29 days). Metal stents were
removed without difficulty and without evidence of de
novo biliary strictures at the time of the stent removal.
Using different endoscopic management strategies, post-
cholecystectomy biliary leak closure was achieved in all
cases, and none of the patients was referred for surgery
(Fig. 2).
0,0%
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Fig. 1 Kaplan-Meier analysis of leak-free survival rates (clinical success) after first endoscopic treatment for cholecystectomy biliary leaks with a
combination of biliary sphincterotomy and the placement of a 10-French plastic stent (solid line) and 95 % CI (dashed line)
Table 3 Univariate analysis of treatment failure in 178 patients
with a combination of biliary sphincterotomy and the
placement of a 10-French biliary stent
Factor Closure of
No - n (%)
The leak
Yes - n (%)
P
Sex Female 6 (6,5) 87 (93,5) 0,216
Male 10 (11,8) 75 (88,2)
Age Mean ± SD 61,5 ± 15,6 64,0 ± 15,4 0,542
Site Cystic duct
stump
9 (8,3) 100 (91,7) 0,017*
CBD/CHD 6 (22,2) 21 (77,8)
Luschka 1 (2,4) 41 (97,6)
Type of leak High-grade 10 (52,6) 9 (47,4) 0,000**
Low-grade 6 (3,8) 153 (96,2)
Interval between
surgery and first
ERCP
Mean ± SD 6,6 + 3,2 7,6 + 3,8 0,314
CBD/CHD Common bile duct/common hepatic duct; SD Standard deviation;
ERCP Endoscopic retrograde cholangiopancreatography
* P <0.05; ** P < 0.01
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Follow-up and adverse events
Three months after being discharged from the hospital,
the patients were evaluated. In total, 151 of 178 patients
demonstrated no evidence of a biliary leak, and they had
no abnormal liver-associated enzyme values (i.e., aspartate
aminotransferase, alanine aminotransferase, alkaline phos-
phatase and gamma glutamyltransferase) and bilirubin
(total and direct). The remaining 27 patients demon-
strated no evidence of biliary leakage, but because of bil-
iary stricture, these 27 patients were treated with multiple
plastic stents for a median time of 12 months.
Adverse events were divided in ERCP related and
stent-related. For the first treatment, complications were
observed in a total of 9 of the 178 (5.1 %) patients: mild
pancreatitis in 5 of 178 (2.8 %) patients, bleeding in 2 of
178 (1.1 %) patients and stent migration in 2 of 178
(1.1 %) patients. The five cases of pancreatitis were man-
aged conservatively, and all five patients recovered with-
out long-term sequelae. The two cases of bleeding were
considered mild and needed no endoscopic treatment to
stop the bleeding. Stent migration was observed in two
patients at the moment of the stent removal. At that
time, the leak was closed, and no further intervention
was needed.
For the second treatment in which 16 patients were
retreated with MPSs, there were no complications re-
lated to ERCP or the stent. Furthermore, for the six
patients who were submitted to FCSEMS, there were no
cases of pancreatitis, metal stent migration, de novo cho-
ledocholithiasis or bile duct strictures found within the
FCSEMS or bile duct at the time of the stent removal.
Discussion
According to the findings of this retrospective, multi-
centre study, endotherapy for postcholecystectomy bil-
iary leaks, with a combination of biliary sphincterotomy
and the placement of a large-bore plastic stent, is associ-
ated with a high success rate (91 %); having a high-grade
biliary leak was the only independent prognostic factor
associated with treatment failure. The use of MPSs as a
rescue therapy for refractory biliary leaks is associated
with clinical failures in approximately 40 % of cases,
particularly in cases of a high-grade leak or after using
fewer than 3 plastic stents. All patients for whom the
placement of MPSs failed were retreated with a FCSEMS,
resulting in leak closures in all cases, suggesting that
refractory biliary leaks should be treated with FCSEMS,
particularly in patients with high-grade leaks. Surgery is
usually not necessary for managing postcholecystectomy
biliary leaks.
Latrogenic injury of the biliary tract wall can occur
as a complication of surgical procedures; bile leak was
the most commonly reported injury, particularly after
cholecystectomy [1, 3, 14]. Furthermore, the advent of
laparoscopic cholecystectomy led to an increase in the
frequency of biliary leaks [1, 3]. Endoscopy (namely
ERCP) is the first line of treatment for such cases.
ERCP diagnoses the biliary lesion and significantly de-
creases the pressure gradient at the ampullary level,
thus allowing a preferential flow of bile from the bile
duct to the duodenum and leading the defect to seal
[1, 3, 5–12]. In 1991, Binmoeller reviewed 77 cases of
endoscopically managed postoperative biliary leaks and
reported a clinical success in 82 % of the cases [24].
Since that report, data published over a 20-year period
(and longer) suggest a success rate of 90 % or better
for leak closure [5]. Several methods, namely nasobili-
ary drains or plastic stents, with or without sphincter-
otomy and biliary sphincterotomy alone, seem to be
equally effective in facilitating the healing of a bile
Table 4 Results of a multivariate logistic model to evaluate
independent predictors for failure of the first endoscopic
treatment in 178 patients
OR P 95 % CI for OR
Lower Upper
Age 0,99 0,657 0,95 1,03
Sex - Male 3,40 0,091 0,82 14,00
Leak site – Cystic duct stump 1,79 0,608 0,19 16,47
Leak site - CBD/CHD 3,62 0,319 0,29 45,34
Type of leak – High grade 26,78 0,000* 6,59 108,83
Interval between surgery and first ERCP 0,89 0,161 0,75 1,05
CI confidence interval; OR odds ratio; CBD/CHD common bile duct/common
hepatic duct; ERCP endoscopic retrograde cholangiopancreatography
* P < 0.01
Table 5 Univariate analysis of treatment failure with two or
more biliary plastic stents (MPSs) used as a rescue endotherapy
after failure of the initial endoscopic treatment
Closure of
No - n (%)
The leak
Yes - n (%)
P
Sex Female 2 (33,3) 4 (66,7) 0,790
Male 4 (40) 6 (60)
Age Mean ± SD 58,2 + 14,2 63,5 + 16,7 0,480
Leak site Cystic duct
stump
2 (22,2) 7 (77,8) 0,118
CBD/CHD 4 (66,7) 2 (33,3)
Luschka 0 (0) 1 (100)
Leak type High-grade 6 (60,0) 4 (40) 0,034*
Low-grade 0 (0) 6 (100)
Maximum number of
plastic stents inserted
Mean ± SD 2,0 ± 0,0 2,8 ± 0,8 0,023*
Maximum plastic
stents diameter
reached, French
Mean ± SD 19,5 ± 0,8 24,0 ± 5,7 0,063
CBD/CHD common bile duct/common hepatic duct; SD standard deviation
* P < 0.05
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leak, and each method has its own limitations and ad-
vantages [5, 8, 25]. In one study, 63 patients with post-
cholecystectomy biliary were randomized to receive a
7-French stent or a 10-French stent; the clinical suc-
cess of each strategy was similar, suggesting that the
stent size does not affect the outcome of endoscopic
intervention [9]. Another group compared biliary
stenting alone with biliary stenting plus sphincterot-
omy and found that the two strategies were equally ef-
fective [10]. However, in a retrospective review of 207
patients, one group, found that high-grade leaks were
better managed with a combination of stents and
sphincterotomy, suggesting that this approach has the
highest potential to seal a leak, particularly in more
complex or problematic leaks [3]. Furthermore, some
authors advocate the use of large bore stents to avoid
early clogging and to improve bile flow [5, 14]. There-
fore, in the institutions where we work, we follow a
standard protocol for biliary leaks that has been used
for the last 10 years, namely biliary sphincterotomy
and the placement of a large bore (10-Fr) stent. In this
study, our clinical success rate was 91 %, which aligns
with previously mentioned studies that have reported a
clinical success rate between 87.1 % and 100 %, al-
though most of the studies used different endoscopic
modalities to seal the leak [1–3, 7, 9, 10, 22, 25]. The
prognostic factors for endotherapy have not been
systematically addressed in previous reports. In this
study, univariate analysis uncovered a biliary leak at
the common bile duct/common hepatic duct, which
was associated with a major injury of the bile duct and
a high-grade biliary leak that proved to be statistically
significant predictors of treatment failure, suggesting
that more complex leaks are more difficult to heal.
Furthermore, a high-grade biliary leak was an inde-
pendent risk factor, according to multivariate analysis,
which might suggest that these types of leaks could be
initially managed with a more aggressive strategy.
However, and despite the widespread and success of
ERCP, there are still reports of difficult to treat com-
plex leaks requiring multiple re-interventions and,
sometimes, surgery [1, 3, 6, 11]. In the last years, two
different strategies have emerged as options to treat re-
fractory biliary leaks: placing a temporary FCSEMS or
upsizing the existing plastic stent or adding additional
plastic stents to further decrease the transpapillary
pressure gradient at a lower cost. In this study, after
failure of the initial therapy, patients with a refractory
leak were submitted to the placement of MPSs avoid-
ing the costs of a FCSEMS. However, in this patient
group, the success rate was only 62.5 %, and the use of
fewer than 3 plastic stents and a high-grade biliary leak
were significant predictors of treatment failure, which
might suggest that using MPSs is only clinically effect-
ive when at least 3 stents are used and that high-grade
leaks should be treated with a FCSEMS. First reported
by Baron et al in 2006 [13], the use of a FCSEMS has
been shown to be clinically effective in treating refrac-
tory biliary leaks at a rate between 90.5 % and 100 %
[14, 15, 18, 20, 26]. Some previous studies have re-
ported complications (i.e., migration and “de novo” bil-
iary strictures at the proximal edge of the stent), and
the development of these strictures was related with long-
term stenting or oversizing (placement of a 10 mm stent
in a duct with a smaller diameter) [18, 26, 27]. However,
in one study, 17 patients with refractory bile leaks were
treated for 30 days or less, with a success rate of 100 %
and without complications, suggesting that short-term
Clinical failure  
6/16 (37.5%) 
Second rescue therapy   
6 patients treated with a   
fully covered metal stent 
Closure of the leak    
6/6 (100%) 
178 patients with a biliary leak treated with     
sphincterotomy+10 Fr plastic stent    
Closure of the leak    
162/178 (91%) 
Closure of the leak   
10/16 (62.5%) 
16 patients with a refractory bile     
leak  treated with more than one     
plastic stent (MPSs)  
Fig. 2 Flow chart of the study
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stenting is efficacious and is not associated with complica-
tions [14]. In this study, six patients were submitted to the
temporary placement of an FCSEMS for 30 days or less,
with success and without complications; this result was
most likely related to the short-term stenting. Further-
more, in this study, removing the SEMS was safe, as sug-
gested in a previous multicentre analysis [27]. Together,
these finding suggest that the use of MPSs is associated
with success in patients with low-grade refractory leaks;
although the treatment time is most often longer than one
week, the increased hospital stays and costs can be com-
pared with the placement of a FCSEMS in future studies.
The present study has several limitations. First, the
retrospective nature limited the number of included
patients because some of the identified consecutive pa-
tients had incomplete data and were excluded from the
analysis. Our data may, therefore, have been subject to
selection bias. Another limitation is that there is no dir-
ect comparison between the two types of rescue therapy
for refractory biliary leaks. We suggest that additional,
prospective, randomized studies are warranted in this
setting. MPS placement must be compared to temporary
placement of a FCSEMS in a large number of patients
with refractory biliary leaks to have adequate power to
detect minor outcome differences. The strengths of our
study are the evaluation of a large number of patients
and using a homogenous approach in an attempt to
maximize the effect of the initial endotherapy and the
evaluation of the available two types of rescue endo-
scopic management for refractory biliary leaks. To the
best of our knowledge, this series is one of the largest
available to analyze the prognostic factors for initial and
revision treatment failures in detail.
Conclusion
In conclusion, ERCP using a standard approach with a
combination of biliary sphincterotomy and the placement
of 10-French plastic stent is associated with a success rate
of 91 % in patients with a postcholecystectomy bile leak.
However, in our series, there were several failures using
MPSs as a strategy for rescue endotherapy, which suggests
that refractory biliary leaks should be treated with
FCSEMS, particularly in patients with high-grade leaks. In
the modern era surgery, is rarely needed to treat postcho-
lecystectomy biliary leaks.
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